MESOTHELIOMA, MALIGNANT
Clinical trials for MESOTHELIOMA, MALIGNANT explained in plain language.
Never miss a new study
Get alerted when new MESOTHELIOMA, MALIGNANT trials appear
Sign up with your email to follow new studies for MESOTHELIOMA, MALIGNANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for aggressive lung cancer
Disease control CompletedThis study tested a new approach for people with malignant mesothelioma, a rare cancer linked to asbestos. Thirty participants received either radiation alone or radiation plus a low-dose chemotherapy drug before surgery. After surgery, some also got two immunotherapy drugs to tr…
Matched conditions: MESOTHELIOMA, MALIGNANT
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Immunotherapy duo shows promise against rare lung cancer
Disease control CompletedThis study tested whether combining two immunotherapy drugs, nivolumab and ipilimumab, works better than standard chemotherapy for Chinese patients with advanced pleural mesothelioma that cannot be removed by surgery. The trial enrolled 102 participants and measured overall survi…
Matched conditions: MESOTHELIOMA, MALIGNANT
Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 04, 2026 16:22 UTC